In 2000, the prevalence was reported as 1 in 150 children, which progressively decreased to 1 in 125 in 2004, 1 in 110 in 2006, 1 in 88 in 2008, 1 in 68 in 2010 and 2012, 1 in 59 in 2014an 2018, and 1 in 36 in 2023 in the U.S
Patients with chronic GI distress often notice meaningful improvement in bloating, regularity, and post-meal discomfort within the first 10 to 14 days
A huge benefit to the research community
These products are not intended to diagnose, treat, cure, or prevent any disease.
A licensed pharmacy must comply with both federal and state laws, which include administrative requirements and quality standards
Nitric oxide modulation: It increases nitric oxide (NO) signaling, improving blood flow to gastric tissues and reducing ischemic injury